Search Results

1 - 8 of 8 items :

  • T regulatory cell x
  • Anatomy and Physiology x
Clear All
CD4/CD8 Antibodies Reduce Histopathological Damage in Salivary Glands of Spontaneously Diabetic Mice

, Belazi M . Histopathological and immunohistochemical features of the labial salivary glands in children with type I diabetes. J Diabetes its Complication 12(1): 39–42, 1998 28. Penaranda C, Tang Q, Bluestone JA . Anti-CD3 Therapy Promotes Tolerance by Selectively Depleting Pathogenic Cells while Preserving Regulatory T Cells. J Immunol 187(4): 2015–22, 2011 29. Parish N, Cooke A . Characterisation of CD8 monoclonal antibody-induced protection from diabetes in NOD mice. Autoimmunity 38(8): 597–604, 2005 30. Yagi H, Matsumoto M, Kunimoto K

Open access
Pathogenesis of Type 1 Diabetes Mellitus: A Brief Overview

. Reijonen H, Daniels TL, Lernmark A, Nepom GT. GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65. Diabetes 49: 1621-1626, 2000. Ludewig B, Odermatt B, Landmann S, Hengartner H, Zinkernagel RM. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med 188: 1493-1501, 1998. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K, Ten S, Sanz M, Exley M, Wilson B, Porcelli S, Maclaren N. Multiple immuno-regulatory

Open access
Fatty Acid Metabolism Disorder as a Factor in Atherogenesis

. Rep. 5: 18366, 2015. 24. Chakravarty B, Gu Z, Chirala SS, Wakil SJ, Quiocho FA. Human fatty acid synthase: Structure and substrate selectivity of the thioesterase domain. J PNAS 101(44): 15567-15572, 2004. 25. Wakil SJ, Abu-Elheiga LA. Fatty acid metabolism: target for metabolic syndrome. J Lipid Res 50: 138-143, 2009. 26. Browne CD, Hindmarsh EJ, Smith JW. Inhibition of endothelial cell proliferation and angiogenesis by orlistat, a fatty acid synthase inhibitor. J FASEB 20(12): 2027-2035, 2006. 27. Kusakabe T, Maeda M, Hoshi N, et

Open access
Gender-Specific Differences of Oxidative Processes in the Population of Circulating Neutrophils of Rats in a Setting of Prolonged Administration of Monosodium Glutamate

, Kudrya MY, Ustenko NV, Nikishina LE, Kravchenko SV. Determination of the concentration of metabolites of nitric oxide in serum. Laboratory diagnostics 3(53): 14-16, 2010. 18. Wellen KE, Thompson CB. Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess. Mol Cell 40(2): 323-332, 2010. 19. Matarrese P, Colasanti T, Ascione B et al. Gender disparity in susceptibility in oxidative stress and autoantibodies specific to RLIP76 in vascular cells. Antiox Redox Signal 15(11): 2825-2836, 2011. 20. Wang X, Desai K, Juurlink B HJ

Open access
Insulin and the Brain

, Morley JE, Horowitz M. Effect of intravenous glucose and euglycemic insulin infusions on short-term appetite and food intake. Am J Physiol 274: R596-R603, 1998. 19. Scherer T, O’Hare J, Diggs-Andrews K et al. Brain insulin controls adipose tissue lipolysis and lipogenesis. Cell Metab 13: 183-194, 2011. 20. Benedict C, Kern W, Schultes B, Born J, Hallschmid M. Differential sensitivity of men and women to anorexigenic and memory-improving effects of intranasal insulin. J Clin Endocrinol Metab 93: 1339-1344, 2008. 21. Hallschmid M, Higgs S

Open access
The pathogenesis of non-alcoholic fatty liver disease is closely related to the metabolic syndrome components

therapy on liver fat content and hepatic insulin sensitivity in patients with type 2 diabetes . Am J Physiol Endocrinol Metab 292: E829-E835, 2007. 15. Katagiri H, Yamada T, Oka Y. Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals. Circ Res 101: 27-39, 2007. 16. Sarafidis PA, Bakris GL . Review: Insulin and endothelin: an interplay contributing to hypertension development? J Clin Endocrinol Metab 92: 379-385, 2007. 17. Bloomgarden ZT. Inflammation

Open access
Update on the Mechanisms Facilitating Weight Loss and Resolution of Type 2 Diabetes Following Bariatric Surgery

Sci 38: 665-673, 1993. 18. O’Halloran DJ, Nikou GC, Kreymann B, Ghatei MA, Bloom SR. Glucagon-like peptide-1 (7-36)-NH2: a physiological inhibitor of gastric acid secretion in man. J Endocrinol 126: 169-173, 1990. 19. Komatsu R, Matsuyama T, Namba M et al. Glucagonostatic and insulinotropic action of glucagonlike peptide I-(7-36)-amide. Diabetes 38: 902-905, 1989. 20. Kashyap SR, Daud S, Kelly KR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic

Open access
Innovative Therapies in Type 2 Diabetes: The Dream of the Future

composition in preclinical models. J Pharmacol Exp Ther 350: 232-242, 2014. 23. Kanwal A, Banerjee SK. SGLT inhibitors: a novel target for diabetes. Pharm Pat Anal 2: 77-91, 2013. 24. Nagasumi K, Esaki R, Iwachidow K et al. Overexpression of GPR40 in pancreatic beta-cells augments glucose-stimulated insulin secretion and improves glucose tolerance in normal and diabetic mice. Diabetes 58: 1067-1076, 2009. 25. Ulven T, Christiansen E. Dietary fatty acids and their potential for controlling metabolic diseases through activation

Open access